FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

Cancer Liaison Program

Cancer News Releases: 2000 - present

2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007| 2008
Archive: 1990's and 1980's

2008

• FDA Clears Test that Helps Identify Type of Cancer in Tumor Sample (July 31)
• FDA Approves New Genetic Test for Patients with Breast Cancer (July 8)
• FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures' (June 17)
• FDA Announces New Labeling Changes for Regranex (June 6)
• FDA Approves Relistor for Opioid-Induced Constipation (April 24)

2007

• FDA Approves Nexavar for Patients with Inoperable Liver Cancer (Nov. 19)
• FDA Strengthens Boxed Warnings, Approves Other Safety Labeling Changes for Erythropoiesis-Stimulating Agents (ESAs) (Nov. 8)
• FDA Approves Tasigna for Treatment of Philadelphia Chromosome Positive Chronic Myeloid Leukemia (Oct. 30)
• FDA Approves Ixempra for Advanced Breast Cancer Patients (Oct. 22)
• FDA Warns of Potential Serious Side Effects with Breakthrough Cancer Pain Drug (Sept. 26)
• FDA Approves New Uses for Evista (Sept. 14)
• FDA Issues Warning Letter to Melanocorp, Inc. For Illegal Sale of Melanotan II (Sept. 5)
• FDA Approves First Molecular-Based Lab Test to Detect Metastatic Breast Cancer (July 16)
• FDA Approves New Drug for Advanced Kidney Cancer (May 30)
• FDA Approves Tykerb for Advanced Breast Cancer Patients (March 13)
• FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs) (March 9, 2007)
• FDA Clears Breast Cancer Specific Molecular Prognostic Test (Feb. 6)

2006

• FDA Expands Use of Herceptin for Early Stage Breast Cancer After Primary Therapy (Nov. 16)
• FDA Approves New Treatment for Advanced Head and Neck Cancer (Oct. 18)
• FDA Approves New Drug for Skin Cancer, Zolinza (Oct. 6)
• FDA Approves a New Drug for Colorectal Cancer, Vectibix (Sept. 27)
  
• FDA Approves Oncaspar for Newly-Diagnosed Acute Lymphoblastic Leukemia (Aug. 2)
• FDA Approves New Imaging System to Help Detect Cervical Pre-Cancer (March 16)
• FDA Approves First Head & Neck Cancer Treatment in 45 Years Data Shows Treatment with Erbitux Extends Survival (March 1)
• New Federal Health Initiative to Improve Cancer Therapy (Feb. 14)
• FDA Approves New Treatment for Gastrointestinal and Kidney Cancer (Jan. 26)

2005

• FDA Approves New Treatment for Myelodysplastic Syndrome (MDS) (Dec. 28)
• FDA Approves New Treatment for Advanced Kidney Cancer (Dec. 20)
• FDA Issues Warning Letters to Marketers of Unapproved 'Alternative Hormone Therapies (Nov. 10)
• FDA Issues Information for Consumers about Claims for Green Tea and Certain Cancers (June 30)
• FDA Names Dr. Richard Pazdur to Lead New Cancer Office (April 22)
• FDA Issues Public Health Advisory Informing Health Care Providers of Safety Concerns Associated with the Use of Two Eczema Drugs, Elidel and Protopic (March 10)

2004

• FDA Statement on Iressa (December 17)
• New Biotechnology Drug Approved to Treat Mucositis Associated with Cancer Treatments (December 15)
• FDA Approves New Drug for the Most Common Type of Lung Cancer (November 19)
• National Recruitment Efforts Underway for Director of Oncology Drug Products in CDER's Office of New Drugs (October 6)
• FDA Approves New Indication for Taxotere -- Prostate Cancer (May 19)
• FDA Approves First in a New Class of Drugs to Treat Hyperparathyroidism Associated With Renal Failure and in Patients With Parathyroid Cancer (March 8)
• FDA Approves First Angiogenesis Inhibitor to Treat Colorectal Cancer (February 26)
• FDA Approves Erbitux for Colorectal Cancer (February 12)
• FDA Approves First Drug for Rare Type of Cancer (February 5)

2003

• FDA Approves New Drug for Advanced Prostate Cancer (November 25)
• FDA Seizes Bogus Dietary Supplement That Claims to Cure Cancer (September 18)
• Federal Investigation Leads to Guilty Plea in Healthcare Crime (June 20)
• NCI and FDA Announce Joint Program to Streamline Cancer Drug Development (May 30)
• FDA Clears Rapid Test for Aspergillus Infection (May 16)
• FDA Approves Velcade for Multiple Myeloma Treatment (May 13)
• FDA Approves New Type of Drug for Lung Cancer (May 5)
• FDA Approves New Drug to Combat Nausea and Vomiting for Cancer Patients Getting Chemotherapy (March 26)
• FDA Warns Public About Misrepresentations in Marketing Claims About Drug to Treat Cancer (March 14)
• FDA Approves New Labels for Estrogen and Estrogen with Progestin Therapies for Postmenopausal Women Following Review of Women's Health Initiative Data (January 8)

2002

• Gleevec Approved as First Line Treatment for Chronic Myeloid Leukemia (December 20)
• FDA Approves Eloxatin for Colorectal Cancer (August 12)
• FDA Clears New Device for Radiation Treatment for Breast Cancer (May 6)
• FDA Approves First Radiopharmaceutical Product to Treat non-Hodgkin's Lymphoma (February 19)
• Protein Patterns May Identify Ovarian Cancer (FDA/NCI) (February 7)

2001

• Maryland Businessman Sentenced for Illegally Marketing Aloe Vera Compounds as AIDS and Cancer Treatments (December 5)
• FDA Alerts Southern Florida Patients to Possibly Inadequate Prostate Cancer Treatments (November 27) The U.S. Food and Drug Administration is alerting certain prostate cancer patients in South Florida to the possibility that they may have been given inadequate levels of the anti-cancer drug Lupron. This alert applies only to prostate cancer patients who have been treated at Urology P.A. -- operated by Dr. Victor Souaid at 2100 East Sample Road, Pompano Beach, Florida.
• Xeloda (capecitabine) from Roche and Taxotere (docetaxel) from Aventis, Inc. received approval on September 10, 2001 for treating patients with metastatic breast cancer whose cancer has progressed after treatment with an anthracycline-containing cancer therapy (such as Adriamycin and doxorubicin).
• Given Diagnostic Imaging System, from Given Imaging Ltd, received approval on August 1, 2001, is a swallowable capsule containing a tiny camera that snaps pictures twice a second as it moves through the small intestine. It is intended to visualize the inside of the small intestine to detect polyps, cancer or causes of bleeding and anemia.
• New Joint Program Announced by FDA and NCI Holds Promise for Cancer Treatment (July 20) The new program, called the Clinical Proteomics Program, melds the study of all proteins in living cells (or proteomics) to the clinical care of patients, the first time this new research technology has been applied directly to patient care.
• Operation Cure All Battle Internet Health Fraud, FDA has joined with the Federal Trade Commission (FTC) and others in a program aimed at stopping Internet scams that promote dietary supplements, devices, and other products as cures or treatments for cancer and other life-threatening diseases. (June 14)
• FDA Approves Gleevec for Leukemia Treatment (May 10)
• FDA Approves Femara as First-Line Therapy for Advanced Breast Cancer (January 10)

2000

• Christian Brothers Contracting Corporation Signs Consent Decree with FDA: Agrees to Stop Selling All Amygdalin / Laetrile Products (November 17)
• FDA Approves New Device to Help Distinguish Harmless From Pre-Cancerous Growths in Colon (November 15)
• FDA Approves Arsenic Trioxide for Leukemia Treatment in Record Time for a Cancer Drug Development Program (September 26)
• FDA Takes Action Against Firms Marketing Unapproved Drugs (September 6)
• FDA Launches Oncology Tools Website, CDER Website Offers Access to Cancer-Related Information (July 7)
• FDA and CTIA to Collaborate on Cell Phone Research (June 8)
• FDA Approves New Surgical Sealant for Lung Cancer (May 30)
• FDA Approves New Cancer Drug, Mylotarg, for the treatment of CD33 positive acute myeloid leukemia. (May 18)

Cancer Liaison Program Home Page

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility

FDA Office of Special Health Issues